The Role of Angiotensin-Converting Enzyme Inhibitors and beta-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. [Review] 

 -  2020 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.119.015327 [doi] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Adrenergic beta-Antagonists/tu [Therapeutic Use]<br/>*Angiotensin-Converting Enzyme Inhibitors/tu [Therapeutic Use]<br/>*Antineoplastic Agents/ae [Adverse Effects]<br/>*Breast Neoplasms/dt [Drug Therapy]<br/>*Heart Diseases/pc [Prevention & Control]<br/>*Primary Prevention<br/>Cardiotoxicity<br/>Female<br/>Heart Diseases/ci [Chemically Induced]<br/>Heart Diseases/pp [Physiopathology]<br/>Humans<br/>Protective Factors<br/>Risk Assessment<br/>Treatment Outcome
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article